TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Patofysiologiska Laboratoriet i Västerås AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
182
|
168
|
166 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
43
|
15
|
4 |
| EBITDA |
36
|
15
|
4 |
| Total assets |
502
|
466
|
490 |
| Current assets |
502
|
466
|
490 |
| Current liabilities |
11
|
11
|
10 |
| Equity capital |
491
|
454
|
480 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
97.8%
|
97.4%
|
98.0% |
| Turnover per employee |
182
|
168
|
166 |
| Profit as a percentage of turnover |
23.6%
|
8.9%
|
2.4% |
| Return on assets (ROA) |
8.6%
|
3.2%
|
0.8% |
| Current ratio |
4563.6%
|
4236.4%
|
4900% |
| Return on equity (ROE) |
8.8%
|
3.3%
|
0.8% |
| Change turnover |
13
|
15
|
4 |
| Change turnover % |
8%
|
10%
|
2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.